• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者在不拔除导管情况下的腹膜炎管理。

Management of peritonitis in a patient on peritoneal dialysis without catheter removal.

作者信息

Al-Zahrani Firas Fahad, Al-Shahrani Hussain, Al-Mohawes Ashwaq, Al-Hwiesh Abdullah, Noor Abdusalam, Abdulrahmn Ibrahiem Saeed

机构信息

Department of Internal Medicine, Security Force Hospital, Dammam, Saudi Arabia.

Department of Internal Medicine, Nephrology Division, King Fahd Hospital of the University, University of Dammam, Dammam, Saudi Arabia.

出版信息

Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):466-469. doi: 10.4103/1319-2442.229290.

DOI:10.4103/1319-2442.229290
PMID:29657222
Abstract

Peritoneal dialysis (PD)-associated peritonitis is an important contributor to morbidity and mortality; Gram-positive bacteria constitute the most frequent associated pathogens (45%-60%) followed by Gram-negative bacteria (25%-40%) and fungal infection (3%-6%). Salmonella peritonitis is an extremely rare cause of peritonitis (0.15%). Peritonitis attributed to Salmonella has been reported only in four cases. Herewith, we report a 68-year-old Sudanese female who presented to our PD unit with abdominal pain and diarrhea and was diagnosed to have Salmonella peritonitis. She was managed without catheter removal. To our knowledge, the association between Salmonella peritonitis due to Salmonella enteritidis in a patient on PD managed without catheter removal has been reported in only one case previously.

摘要

腹膜透析(PD)相关腹膜炎是发病率和死亡率的重要影响因素;革兰氏阳性菌是最常见的相关病原体(45%-60%),其次是革兰氏阴性菌(25%-40%)和真菌感染(3%-6%)。沙门氏菌腹膜炎是腹膜炎极为罕见的病因(0.15%)。仅报道过4例由沙门氏菌引起的腹膜炎。在此,我们报告一名68岁的苏丹女性,她因腹痛和腹泻就诊于我们的腹膜透析科,被诊断为沙门氏菌腹膜炎。她在未拔除导管的情况下接受了治疗。据我们所知,此前仅报道过1例在未拔除导管的情况下接受治疗的腹膜透析患者因肠炎沙门氏菌引起沙门氏菌腹膜炎的病例。

相似文献

1
Management of peritonitis in a patient on peritoneal dialysis without catheter removal.腹膜透析患者在不拔除导管情况下的腹膜炎管理。
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):466-469. doi: 10.4103/1319-2442.229290.
2
Mesorhizobium peritonitis: The first reported case.中生根瘤菌腹膜炎:首例报告病例。
Nephrology (Carlton). 2017 Jan;22(1):96. doi: 10.1111/nep.12716.
3
Discordant PD catheter and effluent culture results. The limited clinical relevance of culturing PD catheters.PD 导管和流出液培养结果不一致。培养 PD 导管的临床相关性有限。
Perit Dial Int. 2011 Mar-Apr;31(2):173-8. doi: 10.3747/pdi.2009.00241. Epub 2010 Jun 17.
4
Automated peritoneal dialysis-related peritonitis due to Salmonella enteritidis in a pediatric patient.小儿患者因肠炎沙门氏菌致自动化腹膜透析相关腹膜炎。
Clin Exp Nephrol. 2012 Apr;16(2):342-4. doi: 10.1007/s10157-011-0541-y. Epub 2011 Oct 4.
5
The culture from peritoneal dialysis catheter enhances yield of microorganism identification in peritoneal dialysis-related peritonitis.腹腔透析导管的培养可提高腹腔透析相关性腹膜炎中微生物鉴定的阳性率。
Perit Dial Int. 2020 Jan;40(1):93-95. doi: 10.1177/0896860819878387.
6
An important causative factor in peritoneal dialysis catheter removal: Salmonella Typhimurium.腹膜透析导管拔除的一个重要致病因素:鼠伤寒沙门氏菌。
Perit Dial Int. 2011 Sep-Oct;31(5):602-3. doi: 10.3747/pdi.2011.00025.
7
A very rare pathogen in peritoneal dialysis peritonitis: .腹膜透析腹膜炎中一种非常罕见的病原体:
Saudi J Kidney Dis Transpl. 2019 May-Jun;30(3):738-740. doi: 10.4103/1319-2442.261363.
8
peritonitis in a peritoneal dialysis patient.腹膜透析患者的腹膜炎
BMJ Case Rep. 2018 Dec 7;11(1):e227713. doi: 10.1136/bcr-2018-227713.
9
Intestinal perforation by a peritoneal dialysis catheter in which fungal peritonitis led to diagnosis: a rare case report.腹膜透析导管致肠穿孔,真菌性腹膜炎由此得以诊断:一例罕见病例报告
CEN Case Rep. 2018 Nov;7(2):208-210. doi: 10.1007/s13730-018-0328-z. Epub 2018 Apr 2.
10
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.多黏菌素E甲磺酸钠在腹膜透析真菌性腹膜炎治疗中的应用失败。
Clin Nephrol. 2011 Jan;75(1):70-3.